SHELL ASSET MANAGEMENT CO - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$648
+4.0%
5,347
-1.7%
0.03%
+8.0%
Q2 2023$623
+3.8%
5,440
+25.1%
0.02%0.0%
Q1 2023$600
+6.0%
4,350
-0.3%
0.02%0.0%
Q4 2022$566
-99.9%
4,365
-16.8%
0.02%
+8.7%
Q3 2022$580,000
+16.9%
5,245
-20.7%
0.02%
+53.3%
Q2 2022$496,000
+15.9%
6,616
+20.7%
0.02%
+50.0%
Q1 2022$428,000
-24.5%
5,481
-12.9%
0.01%
-16.7%
Q4 2021$567,000
-2.2%
6,293
+0.4%
0.01%
-7.7%
Q3 2021$580,000
+14.2%
6,267
-4.1%
0.01%
+30.0%
Q2 2021$508,000
+85.4%
6,537
+77.8%
0.01%
+100.0%
Q1 2021$274,000
-79.3%
3,677
-52.7%
0.01%
-81.5%
Q4 2020$1,326,000
+24.0%
7,776
+2.1%
0.03%
+8.0%
Q3 2020$1,069,000
-26.6%
7,613
-16.2%
0.02%
-30.6%
Q2 2020$1,457,000
+84.9%
9,086
+12.8%
0.04%
+63.6%
Q1 2020$788,000
-37.4%
8,055
-17.4%
0.02%
-18.5%
Q4 2019$1,258,000
+111.1%
9,752
+23.3%
0.03%
+92.9%
Q3 2019$596,000
-68.7%
7,910
-36.9%
0.01%
-66.7%
Q2 2019$1,904,000
+25.9%
12,532
-1.2%
0.04%
+27.3%
Q1 2019$1,512,000
+106.0%
12,683
+88.6%
0.03%
+83.3%
Q4 2018$734,000
-38.0%
6,724
-8.2%
0.02%
-21.7%
Q3 2018$1,183,000
+22.2%
7,3240.0%0.02%
+15.0%
Q2 2018$968,000
+69.2%
7,324
-5.1%
0.02%
+81.8%
Q1 2018$572,000
+33.3%
7,7150.0%0.01%
+22.2%
Q4 2017$429,0007,7150.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders